Strategic Partners A/S
STRAP | CO
Overview
Corporate Details
- ISIN(s):
- DK0062502894 (+1 more)
- LEI:
- 54930025OZD2GGSQ7L42
- Country:
- Denmark
- Address:
- Lyskær 8 A st. tv., 2730 Herlev
- Website:
- https://www.orphazyme.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Orphazyme was founded in Denmark in 2009 on a scientific discovery about the role of heat shock proteins (HSPs), which was described in a well-cited article published in the journal Nature. We translated this scientific discovery into late-stage clinical trials of our investigational drug candidate, arimoclomol, with the aim of developing new treatment options for people with neurodegenerative diseases, such as Niemann-Pick disease type-C (NPC). In May 2022, substantially all of Orphazyme’s assets and business activities, including those relating to the development and approval of arimoclomol, were sold to KemPharm Denmark A/S, a wholly owned subsidiary of KemPharm, Inc.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Strategic Partners A/S.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-14 19:13 |
Major Shareholding Notification
|
Danish | 117.5 KB | |
| 2025-07-14 19:13 |
Major Shareholding Notification
|
Danish | 1.8 KB | |
| 2025-07-14 19:09 |
Director's Dealing
|
Danish | 108.3 KB | |
| 2025-07-14 19:09 |
Related Party Transaction
|
Danish | 81.5 KB | |
| 2025-07-14 19:09 |
Director's Dealing
|
Danish | 1.7 KB | |
| 2025-07-11 21:58 |
Director's Dealing
|
Danish | 87.7 KB | |
| 2025-07-11 21:58 |
Director's Dealing
|
Danish | 1.4 KB | |
| 2025-07-07 17:23 |
Transaction in Own Shares
|
Danish | 2.2 KB | |
| 2025-07-07 17:23 |
Regulatory News Service
|
Danish | 118.4 KB | |
| 2025-07-07 08:54 |
Transaction in Own Shares
|
Danish | 10.1 KB | |
| 2025-07-07 08:54 |
Transaction in Own Shares
|
Danish | 152.4 KB | |
| 2025-06-30 08:36 |
Transaction in Own Shares
|
Danish | 10.1 KB | |
| 2025-06-30 08:36 |
Transaction in Own Shares
|
Danish | 148.9 KB | |
| 2025-06-23 09:35 |
Transaction in Own Shares
|
Danish | 149.4 KB | |
| 2025-06-23 09:35 |
Transaction in Own Shares
|
Danish | 8.5 KB |
Automate Your Workflow. Get a real-time feed of all Strategic Partners A/S filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Strategic Partners A/S via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Medigene AG | Germany | MDG1 | |
|
MedinCell S.A. | France | MEDCL | |
|
Mendus | Sweden | IMMU | |
|
Merchavia Holdings and Investments Ltd. | Israel | MRHL | |
|
Merck KGaA | United States of America | 6MK | |
| Metabolic Nordic AB | Sweden | MBOLIC | ||
|
Modus Therapeutics Holding AB | Sweden | MODTX | |
|
Molecure S.A. | Poland | MOC | |
|
M WINKWORTH PLC | United Kingdom | WINK | |
|
Mycodern Spolka Akcyjna | Poland | MCD |